Adrenergic pharmacology: Focus on the central nervous system

CNS Spectrums

Volumn 6, Issue 8, 2001, Pages 656-662

  Pupo, Andre S ^a   Minneman, Kenneth P ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] 4,4 DIMETHYL 1,3(2H,4H) ISOQUINOLINEDIONE; 3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; 4 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL]PHENOXYACETIC ACID; 5 METHYLURAPIDIL; 5 [2 [[2 HYDROXY 3 [4 (1 METHYL 4 TRIFLUOROMETHYL 2 IMIDAZOLYL)PHENOXY]PROPYL]AMINO]ETHOXY]SALICYLAMIDE; 8 [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] 8 AZASPIRO[4.5]DECANE 7,9 DIONE; ADRENALIN; ADRENERGIC RECEPTOR; ADRENERGIC RECEPTOR BLOCKING AGENT; ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; BRIMONIDINE; CATECHOLAMINE; CLONIDINE; ISOPRENALINE; METHOXAMINE; NIGULDIPINE; NORADRENALIN; OXYMETAZOLINE; PHENYLEPHRINE; PRAZOSIN; PROPRANOLOL; RAUWOLSCINE; SALBUTAMOL; TERBUTALINE; UNINDEXED DRUG; XAMOTEROL; YOHIMBINE;

ADRENERGIC SYSTEM; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM; PRIORITY JOURNAL; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION;

EID: 0035564729     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1092852900001346     Document Type: Review

References (60)

1. Nucleus locus ceruleus: New evidence of anatomical and physiological specificity
2. Central catecholamine neurons as revealed by immunohistochemistry with special reference to adrenaline neurons
3. International Union of Pharmacology nomenclature of adrenoceptors
4. International Union of Pharmacology. X. Recommendation for nomenclature of alpha 1-adrenoceptors: Consensus update
5. The beta2-adrenergic receptor interacts with the Na+/H+-exchanger regulatory factor to control Na+/H+ exchange
6. Beta 1-adrenergic receptor association with PSD-95. Inhibition of receptor internalization and facilitation of beta 1-adrenergic receptor interaction with N-methyl-D-aspartate receptors
7. A study of adrenotropic receptors
8. Differentiation of receptor systems activated by sympathomimetic amines
9. Molecular characterization of the human beta 3-adrenergic receptor
10. The contribution of classical (beta1/2-) and atypical beta-adrenoceptors to the stimulation of human white adipocyte lipolysis and right atrial appendage contraction by novel beta3-adrenoceptor agonists of differing selectivities
11. Selectivity of agonists for cloned alpha 1-adrenergic receptor subtypes
12. Design and synthesis of novel alphala adrenoceptor-selective dihydropyridine antagonists for the treatment of benign prostatic hyperplasia
13. Use of recombinant alpha 1-adrenoceptors to characterize subtype selectivity of drugs for the treatment of prostatic hypertrophy
14. (+)-Niguldipine binds with very high affinity to Ca2+ channels and to a subtype of alpha 1-adrenoceptors
15. Discovery of alpha 1a-adrenergic receptor antagonists based on the L-type Ca2+ channel antagonist niguldipine
16. 5-Methyl-urapidil discriminates between subtypes of the alpha 1-adrenoceptor
17. Characterization of alpha 1-adrenergic receptor subtypes in rat brain: A reevaluation of [3H]WB4104 and [3H]prazosin binding
18. BMY 7378 is a selective antagonist of the D subtype of alpha 1-adrenoceptors
19. Central hypotensive effects of the alpha2a-adrenergic receptor subtype
20. Insights front in vivo modification of adrenergic receptor gene expression
21. Antisense technology reveals the alpha2A adrenoceptor to be the subtype mediating the hypnotic response to the highly selective agonist, dexmedetomidine, in the locus coeruleus of the rat
22. Barrier mechanisms for neurotransmitter monoamines and their precursors at the blood-brain interface
23. Phenylephrine-induced activity in mice as a model of central alpha 1-adrenoceptor function. Effects of acute and repeated administration of antidepressant drugs and electroconvulsive shock
24. Role of central alpha-1 adrenoceptors in canine narcolepsy
25. A lipophilic, selective alphal-adrenoceptor agonist: 2-(2-chloro-5-trifluoromethylphenylimino)imida-zolidine (St587)
26. Possible function of alpha 1-adrenoceptors in the CNS in anaesthetized and conscious animals
27. Relationship between activity and structure in derivatives of clonidine
28. Pharmacokinetics of clonidine in the rat and cat
29. Brain sites for the antihypertensive action of clonidine
30. Centrally acting antihypertensives: A renaissance of interest. Mechanisms and haemodynamics
31. Pharmacological characteristics of alpha-2 adrenergic receptor subtypes
32. Alpha-2 and imidazoline receptor agonists. Their pharmacology and therapeutic role
33. Brain uptake of radiolabeled amino acids, amines, and hexoses after arterial injection
34. Interaction of beta adrenergic agonists and antagonists with brain beta adrenergic receptors in vivo
35. Effects of clenbuterol and antidepressant drugs on beta adrenergic receptor/N-protein coupling in the cerebral cortex of the rat
36. Discriminative stimulus effects of centrally administered isoproterenol in rats: Mediation by beta-1 adrenergic receptors
37. Pharmacological properties of beta 3-adrenoceptors
38. The metabolic fate of prazosin
39. Clinical pharmacokinetics of prazosin
40. Prazosin selectively antagonizes neuronal responses mediated by alpha1-adrenoceptors in brain
41. Pharmacological evidence for the role of central alpha 1B-adrenoceptors in the motor activity and spontaneous movement of mice
42. Distribution and metabolism of tritiated yohimbine in mice
43. Alpha 2 receptors mediate the antinociceptive action of 8-OH-DPAT in the hot-plate test in mice
44. Studies on the absorption, distribution and excretion of propranolol in rat, dog and monkey
45. Tissue levels of several radiolabeled beta-adrenoceptor antagonists after intravenous administration in rats
46. Localization of mRNA for three distinct alpha 1-adrenergic receptor subtypes in human tissues: Implications for human alpha-adrenergic physiology
47. Expression of alpha 1-adrenergic receptor subtype mRNA in rat tissues and human SK-N-MC neuronal cells: Implications for alpha 1-adrenergic receptor subtype classification
48. Distribution of alpha 1 adrenoceptors in rat brain revealed by in situ hybridization experiments utilizing subtype-specific probes
49. Expression of multiple alpha adrenergic receptor subtype messenger RNAs in the adult rat brain
50. Distribution of alpha 1a-, alpha 1b- and alpha 1d-adrenergic receptor mRNA in the rat brain and spinal cord
51. Distributions of mRNAs for alpha-2 adrenergic receptor subtypes in rat brain: An in situ hybridization study
52. Distribution of alpha 2-adrenergic receptor subtype gene expression in rat brain
53. Distribution of alpha 2C-adrenergic receptor-like immunoreactivity in the rat central nervous system
54. Distribution of alpha 2A-adrenergic receptor-like immunoreactivhy in the rat central nervous system
55. Localization of alpha2Cadrenergic receptor immunoreactivity in catecholaminergic neurons in the rat central nervous system
56. Cellular localization of messenger RNA for beta-1 and beta-2 adrenergic receptors in rat brain: An in situ hybridization study
57. Expression of beta 3-adrenoceptor mRNA in rat brain
58. The distribution and significance of CNS adrenoceptors examined with in situ hybridization
59. Food intake of lean and obese Zucker rats following ventricular infusions of adrenergic agonists